We are live on
!
Find out more
IPCP
Iron Park Capital Partners Portfolio holdings
AUM
$621K
1-Year Est. Return
73.14%
This Fund
S&P 500
This Quarter
Est. Return
-68.39%
1 Year Est. Return
-73.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$621K
AUM Growth
-$6.81M
(-92%)
Cap. Flow
-$5.46M
Cap. Flow
% of AUM
-879.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TriSalus Life Sciences
TLSI
|
+$5.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0% |
Similar funds
EVCM
AC
SHG
EC
RIR
FWM
SKCP
OP
Iron Park Capital Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Iron Park Capital Partners held 2 positions worth $621K, down 92% from $7.43M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Iron Park Capital Partners withdrew a net $5.46M in Q4 2022, closing 1 position. Its most notable exit was TriSalus Life Sciences, an estimated $5.46M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 74% a quarter earlier.
- Iron Park Capital Partners fully exited TriSalus Life Sciences in Q4 2022, selling an estimated $5.46M.
- Iron Park Capital Partners's ten largest holdings make up 100% of its $621K portfolio in Q4 2022.
- Iron Park Capital Partners opened 0 new positions and closed 1 in Q4 2022.
- Iron Park Capital Partners's portfolio value fell 92% quarter-over-quarter to $621K.
Based on Iron Park Capital Partners's 13F filing for Q4 2022, filed 31 Jan 2023.